nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—MDM2—ocular cancer	0.00308	0.00308	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—MYC—ocular cancer	0.00307	0.00307	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TGFB1—ocular cancer	0.00306	0.00306	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—GNA11—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—E2F5—ocular cancer	0.00301	0.00301	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—E2F4—ocular cancer	0.00295	0.00295	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—GNAQ—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RBL1—ocular cancer	0.0029	0.0029	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—HRAS—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—HRAS—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—GNAQ—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—GNA11—ocular cancer	0.00274	0.00274	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—HDAC1—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—GNAQ—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—MDM2—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TP53—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—E2F3—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TFDP1—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—TGFB1—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—MDM2—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Ketamine—OPRM1—IL4-mediated signaling events—AKT1—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—MDM2—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PSPH—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—HRAS—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—HRAS—ocular cancer	0.002	0.002	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SAG—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CDK4—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAML2—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CDK4—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—HRAS—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—AKT1—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—HRAS—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—CDK4—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—AKT1—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNA11—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—E2F5—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—HRAS—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SAG—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—TGFB1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—E2F4—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Ketamine—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PSPH—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RBL1—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GNA11—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—AKT1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNAQ—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNA11—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GNAQ—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNA11—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—E2F5—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—E2F4—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNAQ—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RBL1—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SAG—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—E2F3—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—HRAS—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNAQ—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PSPH—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HDAC1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNA11—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TFDP1—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNA11—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—E2F5—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNAQ—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—E2F3—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—E2F4—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDKN2B—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—HRAS—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RBL1—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PSPH—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—HRAS—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNAQ—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TFDP1—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNA11—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PSPH—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EP300—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—E2F1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EP300—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SAG—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—HRAS—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNAQ—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—EP300—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—E2F3—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—HRAS—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAML2—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TFDP1—ocular cancer	0.000975	0.000975	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TGFB1—ocular cancer	0.000974	0.000974	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000963	0.000963	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNA11—ocular cancer	0.000954	0.000954	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—E2F5—ocular cancer	0.000954	0.000954	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TGFB1—ocular cancer	0.00095	0.00095	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—E2F4—ocular cancer	0.000934	0.000934	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RBL1—ocular cancer	0.000916	0.000916	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAML2—ocular cancer	0.000916	0.000916	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNA11—ocular cancer	0.000911	0.000911	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNAQ—ocular cancer	0.000887	0.000887	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNA11—ocular cancer	0.000867	0.000867	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000849	0.000849	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNAQ—ocular cancer	0.000847	0.000847	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNAQ—ocular cancer	0.000806	0.000806	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNA11—ocular cancer	0.000799	0.000799	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—E2F3—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000775	0.000775	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAML2—ocular cancer	0.000774	0.000774	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—HRAS—ocular cancer	0.000767	0.000767	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HDAC1—ocular cancer	0.000764	0.000764	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—ocular cancer	0.000756	0.000756	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—HRAS—ocular cancer	0.000748	0.000748	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNAQ—ocular cancer	0.000743	0.000743	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PSPH—ocular cancer	0.000742	0.000742	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00074	0.00074	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TFDP1—ocular cancer	0.000739	0.000739	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000716	0.000716	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN2B—ocular cancer	0.000685	0.000685	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000681	0.000681	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—AKT1—ocular cancer	0.000677	0.000677	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNA11—ocular cancer	0.000675	0.000675	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MDM2—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNA11—ocular cancer	0.000673	0.000673	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HDAC1—ocular cancer	0.00067	0.00067	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—AKT1—ocular cancer	0.00066	0.00066	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—E2F1—ocular cancer	0.000628	0.000628	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNAQ—ocular cancer	0.000628	0.000628	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HRAS—ocular cancer	0.000626	0.000626	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNAQ—ocular cancer	0.000626	0.000626	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDKN1B—ocular cancer	0.000616	0.000616	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AKT1—ocular cancer	0.000609	0.000609	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN2B—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000593	0.000593	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCND1—ocular cancer	0.000587	0.000587	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAML2—ocular cancer	0.000587	0.000587	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDKN1A—ocular cancer	0.000568	0.000568	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HDAC1—ocular cancer	0.000566	0.000566	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AKT1—ocular cancer	0.000553	0.000553	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—E2F1—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EP300—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNA11—ocular cancer	0.000514	0.000514	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNA11—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000507	0.000507	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000505	0.000505	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000487	0.000487	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNAQ—ocular cancer	0.000478	0.000478	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNAQ—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—ocular cancer	0.000471	0.000471	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—ocular cancer	0.00047	0.00047	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—E2F1—ocular cancer	0.000466	0.000466	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNA11—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HDAC1—ocular cancer	0.000429	0.000429	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—ocular cancer	0.000387	0.000387	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MDM2—ocular cancer	0.00038	0.00038	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNA11—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNA11—ocular cancer	0.000354	0.000354	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000353	0.000353	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—ocular cancer	0.000353	0.000353	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNAQ—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MDM2—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000329	0.000329	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1A—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—ocular cancer	0.00029	0.00029	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNA11—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—ocular cancer	0.000122	0.000122	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—ocular cancer	8.78e-05	8.78e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—ocular cancer	7.8e-05	7.8e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—ocular cancer	7.65e-05	7.65e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—ocular cancer	7.15e-05	7.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—ocular cancer	4.71e-05	4.71e-05	CbGpPWpGaD
